Sign in Subscribe
Digoxin

Digoxin and Sodium Valproate Show Potential in Drug-Resistant Epilepsy Treatment

Strategic Insights

— 2 min read

Current research by National University of Pharmacy suggests that cardiac glycoside digoxin may be an effective adjuvant to classical antiepileptic drugs (AEDs) in treating drug-resistant epilepsy. The study aims to elucidate the role of individual markers of neuroinflammation and neuronal apoptosis in the realization of the anticonvulsant potential of digoxin and sodium valproate. The results show that the combination of digoxin with sodium valproate more effectively prevents the development of seizures than monotherapy, and that both medications exhibit pronounced anti-inflammatory properties.

Key Takeaways:

  • The combination of digoxin and sodium valproate may be an effective treatment for drug-resistant epilepsy, with a more significant effect than monotherapy.
  • Digoxin and sodium valproate exhibit pronounced anti-inflammatory properties, restoring the content of TNF-a and increasing the expression of IL-4.
  • The combination of digoxin and sodium valproate normalizes the level of 5-LOX in the brain and counteracts neuroapoptosis and neurodegeneration.
  • Cerebral NOS is not involved in the development of experimental seizures nor in the anticonvulsant effect of sodium valproate and digoxin.
  • The study provides new insights into the mechanisms of anticonvulsant action of digoxin and sodium valproate, which may be important in developing new strategies for drug-resistant epilepsy treatment.
  • The researchers used a model of chronic epileptogenesis induced by pentylenetetrazole (PTZ) in mice, with 40 animals divided into five groups to test the effects of digoxin, sodium valproate, and their combination.
  • The study was conducted by researchers from National University of Pharmacy, including V.V. Tsyvunin, S.Yu. Shtrygol', and D.V. Lytkin.

Statistics:

  • 40 mice were used in the study, divided into five groups of eight mice each.
  • The combination of digoxin and sodium valproate resulted in a more significant reduction in seizures than monotherapy.
  • The levels of TNF-a and IL-4 were restored, and 5-LOX was normalized in the brain.
  • Cerebral NOS was not involved in the development of experimental seizures or the anticonvulsant effect of sodium valproate and digoxin.

Sources:

  • Impact of digoxin and sodium valproate on the mechanisms of neuroinflammation and neuroapoptosis under experimental epileptogenesis. Medicni Perspektivi, 2025, 30(3): 230-238.
  • doi-org.sdpl.idm.oclc.org/10.26641/2307-0404.2025.3.340812
  • National University of Pharmacy
  • Dnipro State Medical University (publisher of Medicni Perspektivi)
  • V.V. Tsyvunin, S.Yu. Shtrygol', D.V. Lytkin (authors)
  • NewsRx LLC (cited as: NewsRx. Researchers' from National University of Pharmacy Report Details of New Studies and Findings in the Area of Antiarrhythmic Agents (Impact of digoxin and sodium valproate on the mechanisms of neuroinflammation and neuroapoptosis under ...). Health & Medicine Week. October 24, 2025; p 6801.)

Read more